Specialty Drug Claims Costs Expected to Rise Almost 20 Percent

by Admin | October 27, 2016 2:52 pm

October 27, 2016—Healthcare payers expect claims costs for specialty and biotech drugs to rise by almost 20 percent next year, a leading health benefits consulting firm says.  

---

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Source URL: https://340binformed.org/2016/10/specialty-drug-claims-costs-expected-to-rise-almost-20-percent/

---